DK645687A - PROCEDURE FOR PREPARING A VACCINE AGAINST HEPATITIS B AND THE VACCINE OBTAINED - Google Patents

PROCEDURE FOR PREPARING A VACCINE AGAINST HEPATITIS B AND THE VACCINE OBTAINED

Info

Publication number
DK645687A
DK645687A DK645687A DK645687A DK645687A DK 645687 A DK645687 A DK 645687A DK 645687 A DK645687 A DK 645687A DK 645687 A DK645687 A DK 645687A DK 645687 A DK645687 A DK 645687A
Authority
DK
Denmark
Prior art keywords
vaccine
preparing
procedure
zonal
subjected
Prior art date
Application number
DK645687A
Other languages
Danish (da)
Other versions
DK645687D0 (en
Inventor
Philippe Jean Adamowicz
Marie Noelle Mevelec
Marc Girard
Original Assignee
Pasteur Vaccins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Vaccins filed Critical Pasteur Vaccins
Publication of DK645687D0 publication Critical patent/DK645687D0/en
Publication of DK645687A publication Critical patent/DK645687A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Particles of hepatitis B virus surface antigens (HBsAg) are produced by expression from a culture of CHO cells transfected with a plasmid, recovering the culture supernatant which, after sterilising filtration, is concentrated and subjected to a fractional precipitation with PEG, the precipitate being taken up and subjected to a zonal velocity centrifugation and then to a zonal flotation centrifugation, following which chromatography is performed in an anion exchanger medium. The vaccine is noteworthy for its purity and its immunogenicity, in particular for its capacity for inducing anti-pre-S2 antibodies.
DK645687A 1986-12-10 1987-12-09 PROCEDURE FOR PREPARING A VACCINE AGAINST HEPATITIS B AND THE VACCINE OBTAINED DK645687A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8617265A FR2608052B1 (en) 1986-12-10 1986-12-10 PROCESS FOR THE PREPARATION OF A HEPATITIS B VACCINE AND VACCINE OBTAINED

Publications (2)

Publication Number Publication Date
DK645687D0 DK645687D0 (en) 1987-12-09
DK645687A true DK645687A (en) 1988-06-11

Family

ID=9341743

Family Applications (1)

Application Number Title Priority Date Filing Date
DK645687A DK645687A (en) 1986-12-10 1987-12-09 PROCEDURE FOR PREPARING A VACCINE AGAINST HEPATITIS B AND THE VACCINE OBTAINED

Country Status (11)

Country Link
EP (1) EP0273811B1 (en)
JP (1) JPS63215639A (en)
KR (1) KR880007732A (en)
AT (1) ATE109353T1 (en)
CA (1) CA1306689C (en)
DE (1) DE3750330T2 (en)
DK (1) DK645687A (en)
FR (1) FR2608052B1 (en)
IL (1) IL84729A (en)
NO (1) NO171147C (en)
PT (1) PT86321B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1073604A (en) * 1991-12-01 1993-06-30 高真南 The method for preparing higher immunogenic hepatitis B vaccine
WO1993012815A1 (en) * 1991-12-27 1993-07-08 Gensci Limited Method for obtaining recombinant surface antigen of hepatitis b, antigen and vaccine based on it

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1356413A (en) * 1971-09-09 1974-06-12 Pfizer Ltd Method of obtaining purified australia antigen from blood serum
US4088748A (en) * 1976-11-02 1978-05-09 Merck & Co., Inc. Hepatitis B surface antigen
US4162192A (en) * 1978-09-28 1979-07-24 Juridical Foundation Method for purification of HBs antigen
FR2560890B1 (en) * 1984-03-07 1987-10-16 Grp Genie Genetique COMPOSITION USEFUL FOR THE MANUFACTURE OF VACCINES CONTAINING PARTICLES CARRYING THE SURFACE ANTIGEN OF HEPATITIS B VIRUS AND THE POLYMERIZED HUMAN SERUM ALBUMIN RECEPTOR, ANIMAL CELLS CAPABLE OF PRODUCING SUCH PARTICLES
US4624918A (en) * 1984-07-09 1986-11-25 Genentech, Inc. Purification process for hepatitis surface antigen and product thereof
US4683294A (en) * 1985-04-03 1987-07-28 Smith Kline Rit, S.A. Process for the extraction and purification of proteins from culture media producing them

Also Published As

Publication number Publication date
IL84729A0 (en) 1988-05-31
EP0273811A3 (en) 1988-08-03
CA1306689C (en) 1992-08-25
DE3750330T2 (en) 1994-11-17
NO171147C (en) 1993-02-03
NO875142D0 (en) 1987-12-09
EP0273811B1 (en) 1994-08-03
EP0273811A2 (en) 1988-07-06
JPS63215639A (en) 1988-09-08
PT86321B (en) 1990-11-07
DE3750330D1 (en) 1994-09-08
DK645687D0 (en) 1987-12-09
NO875142L (en) 1988-06-13
IL84729A (en) 1993-02-21
FR2608052A1 (en) 1988-06-17
KR880007732A (en) 1988-08-29
ATE109353T1 (en) 1994-08-15
NO171147B (en) 1992-10-26
FR2608052B1 (en) 1990-04-13
PT86321A (en) 1988-01-01

Similar Documents

Publication Publication Date Title
EP0584348A4 (en) Genetic vaccine for immunodeficiency viruses
FI102616B1 (en) Method for producing a vaccine against type 3 human parainfluenza virus and expression system useful in the method
NO167359C (en) PROCEDURE FOR THE PREPARATION OF A VACCINE AGAINST INFECTION OF HEPATITIS B VIRUS.
AU5572786A (en) Expression of immunologically reactive aids viral protein
DK27287D0 (en) PROCEDURE FOR THE PREPARATION OF PERTUSSIS ANTIGENS
DK482788D0 (en) VACCINES AGAINST AND DIAGNOSTIC PROVISIONS OF HAEMOPHILUS INFLUENZAE
DK645687A (en) PROCEDURE FOR PREPARING A VACCINE AGAINST HEPATITIS B AND THE VACCINE OBTAINED
AU2865084A (en) Virus antigen, preparation process thereof and its utilisation in diagnostic and therapy (vaccine)
ZA857610B (en) Hepatitis b antigenic compositions and vaccines against hepatitis b derived therefrom
DK0480525T3 (en) Method for obtaining recombinant hepatitis B virus (HEP B) surface antigen with greater immunogenic capacity and using
DK0593339T3 (en) Process for the preparation of hepatitis A (HAV) antigen and vaccine
HK126095A (en) Hepatitis a virus vaccines
FR2604183B1 (en) DNA SEQUENCE, VECTORS, RECOMBINANT VIRUSES AND METHOD USING RECOMBINANT VACCINE VIRUSES CAPABLE OF MULTIPLYING IN CHO CELLS
DK312687D0 (en) VARICELLA-ZOSTER VIRUS (VZV), PROCEDURES FOR PREPARING THEREOF AND VACCINE CONTAINING VZV
DK0408742T3 (en) Method of Preparation and Purification of Hepatitis B Vaccine
Gerin et al. Recombinant DNA and synthetic peptide approaches to HBV vaccine development: Immunogenicity and protective efficacy in chimpanzees.
Michel et al. Synthesis and secretion of hepatitis-B surface antigen particles in transfected animal cells.
PT72045B (en) Process for preparing vaccines for swine protection
Leboulleux et al. Loss of anti-HBc antibodies after HBV infection in immunized Senegalese children
BR9705324C1 (en) Method for producing purified hbsag for vaccine preparation and recombinant vaccine against type b hepatitis
AR212170A1 (en) MEDIA FOR CULTIVATION OF CELLS FOR THE PRODUCTION OF VIRUSES USABLE IN THE PREPARATION OF VACCINES AND A PROCEDURE FOR THE PREPARATION OF A VACCINE BY MEANS OF SUCH A CULTURE MEDIA

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment